Zogenix (ZGNX) Zohydro ER Fails to Win FDA Panel Backing
- Apple (AAPL), China Mobile (CHL) Sign iPhone Deal - WSJ
- Market Wrap: Hayman Likes GM; Pandora Skirts Competition; Private Sector Jobs Bonanza
- After Hours Stock Movers 12/4: (PBYI) (MFRM) (GGP) Higher; (LGP) (SNPS) (ARO) Lower (more...)
- General Growth Properties (GGP) Set to Join the S&P 500
- Fed Saw 'Modest to Moderate' Growth with Stronger Manufacturing
Zogenix (Nasdaq: ZGNX) Zohydro ER fails to win FDA panel backing.
You May Also Be Interested In
- Ambit Biosciences (AMBI) Will Not Submit NDA for Accelerated Quizartinib Approval
- Mylan (MYL) Completes Agila Injectivles Purchase
- ARCA biopharma (ABIO) Gencaro IND for AF Accepted by FDA
Create E-mail Alert Related CategoriesCorporate News, FDA, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!